Discover and read the best of Twitter Threads about #ThePowerOfZero
Most recents (3)
Intro to #CAC Tweetorial!
For #ACCFIT, @FiRSTSCCT @ACRRFS #ACCImaging,
@heart_scct #YesCCT #AHA18 #SCCT2019 #Cardiotwitter 😀😀
*⃣Case
*⃣Basics on CAC
*⃣CAC & prognosis
*⃣ACC/AHA 2018 vs SCCT 2017 guidelines
*⃣Case follow-up
(1/n)
For #ACCFIT, @FiRSTSCCT @ACRRFS #ACCImaging,
@heart_scct #YesCCT #AHA18 #SCCT2019 #Cardiotwitter 😀😀
*⃣Case
*⃣Basics on CAC
*⃣CAC & prognosis
*⃣ACC/AHA 2018 vs SCCT 2017 guidelines
*⃣Case follow-up
(1/n)
Here’s a case – similar to patients we see everyday in the primary care and cardiology offices. (2/n)
72 year-old asymptomatic healthy 💃
BP 117/74, BMI 22
Lipids: TC 270, TG 100 HDL 90 LDL 155
ACC/AHA ASCVD Risk: 10%
#AHA2018 #YesCCT #CAC #ACCImaging
72 year-old asymptomatic healthy 💃
BP 117/74, BMI 22
Lipids: TC 270, TG 100 HDL 90 LDL 155
ACC/AHA ASCVD Risk: 10%
#AHA2018 #YesCCT #CAC #ACCImaging
POLL:
Based on the clinical information, would you (3/n):
#AHA2018 #YesCCT #CAC #SCCT2019 #ACCImaging #Cardiotwitter
Based on the clinical information, would you (3/n):
#AHA2018 #YesCCT #CAC #SCCT2019 #ACCImaging #Cardiotwitter
No benefit from #statins in patients with a #CAC score of zero
#ThePowerOfZero by #YesCCT shown again @JACCJournals by @lesleejshaw
@Heart_SCCT @AChoiHeart @khurramn1 @ghoshhajra
@MichaelJBlaha @RonBlankstein @ErinMichos @DrMarthaGulati @gina_lundberg @ChinnaiyanMD
#ThePowerOfZero by #YesCCT shown again @JACCJournals by @lesleejshaw
@Heart_SCCT @AChoiHeart @khurramn1 @ghoshhajra
@MichaelJBlaha @RonBlankstein @ErinMichos @DrMarthaGulati @gina_lundberg @ChinnaiyanMD
Big win for #CAC in 2018 Cholesterol Guidelines just published @CircAHA
#CAC is now recommended for risk reclassification in low & intermediate risk patients to guide decision making for statin therapy
ahajournals.org/doi/10.1161/CI…
@AHAMeetings @MichaelJBlaha @ASPCardio @AHAScience
#CAC is now recommended for risk reclassification in low & intermediate risk patients to guide decision making for statin therapy
ahajournals.org/doi/10.1161/CI…
@AHAMeetings @MichaelJBlaha @ASPCardio @AHAScience
With 5 days to Chol management guidelines update @AHAMeetings..gentle reminder in @JACCJournals: It’s time to accept the #PowerOfZero.
Hope it’s not too late! @rblument1 @hmkyale @MichaelJBlaha @RonBlankstein @ErinMichos @MBittencourtMD.
Some thoughts👇
onlinejacc.org/content/early/…
Hope it’s not too late! @rblument1 @hmkyale @MichaelJBlaha @RonBlankstein @ErinMichos @MBittencourtMD.
Some thoughts👇
onlinejacc.org/content/early/…
#1 Going back to early 2000’s when many showed RF-based approach fell short for individual patient management decisions... aspirations for CAC ‘screening’ gained momentum, though progress stalled due to lack of RCT & waiting for prospective cohorts to confirm prognostication
#3, while hard to rationalize @NIH aversion to fund much needed RCT, sig progress with MESA & HNR confirmed CAC risk stratification capacity->In 2010 Class IIa rec for ‘screen-detect disease-treat’. At that time many hoped next guidelines update wud strengthen CAC screening recs
